<DOC>
	<DOCNO>NCT01928979</DOCNO>
	<brief_summary>Thrombus outcome data collect retrospectively 2011-2012 historical baseline SoC oral VKA ( Vitamin K Antagonist ( ) treatment patient nonvalvular AF atrial flutter document LA/ LAA thrombi transesophag-eal echocardiography ( TEE ) . The study company-sponsored , global , multi-center , retrospective , non-interventional study . Patients suffer hemodynamically stable nonvalvular AF atrial flutter diagnose LA/ LAA thrombus January 1st , 2011 December 31st , 2012 identify screen review medical record include registry . Retrospective patient data collect May 2nd , 2013 May 2nd , 2014 . The observation patient cover period diagnosis LA/ LAA thrombus end-of-treatment TEE follow 3-12 week SoC anticoagulation ( AC ) therapy . If end-of-treatment TEE perform 3-12 week AC therapy , observational period end 12 week diagnosis late . If one TEE perform treatment , thrombus outcome collect last TEE perform within 12 week treatment start .</brief_summary>
	<brief_title>Retrospective Registry Providing Baseline Data Outcome Left Atrial ( LA ) LA Appendage ( LAA ) Thrombus Patients With Nonvalvular Atrial Fibrillation ( AF ) Atrial Flutter After Standard Care ( SoC ) Anticoagulant Therapy</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atrial Flutter</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Men woman age â‰¥ 18 year data record Hemodynamically stable nonvalvular AF atrial flutter Documented LA/ LA thrombus TEE Valvular AF ( ESC 2012 definition ) History cardiac thrombus confirm TEE Intracardiac tumor , e.g . atrial myxoma Active endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>LA/LAA Thrombus</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Observation</keyword>
</DOC>